Stereotaxis Inc (STXS)
Stereotaxis, Inc. is a healthcare equipment and supplies company focused on robotic technologies for interventional laboratories in the United States and international markets. The company develops and sells robotic magnetic navigation systems, including Genesis RMN and GenesisX RMN, which are designed to help physicians carry out complex catheter-based procedures with image-guided control. Its product line also includes the Odyssey information platform, together with Synchrony and SynX solutions, which support the management, recording, control, and sharing of procedure data across networks. Stereotaxis additionally supplies x-ray systems, disposables, accessories, and interventional devices under brands such as Map-iT, MAGiC, and EMAGIN. The company sells its products through a direct sales force as well as distributors and sales agents. Founded in 1990, Stereotaxis is based in Saint Louis, Missouri.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-STXS
|
$1.19
|
-10.6% Downside
|
Fair
|
$3
|
125.6% Upside
|
Bargain
|
Weak
|
0.0%
|
November 5, 2026
|
10.6x
|
4.3x
|
133.3 M
|
129.2 M
|
3.7%
|
65.4%
|
-16.6
|
65.7%
|
